N-(2-Pyridyl)bis(trifluoromethanesulfonimide) Cas:145100-50-1

We are N-(2-Pyridyl)bis(trifluoromethanesulfonimide) CAS:145100-50-1 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests


N-(2-Pyridyl)bis(trifluoromethanesulfonimide)

Synonyms:
2-[N,N-Bis(trifluoromethylsulfonyl)amino]pyridine
N,N-Bis(trifluoromethylsulfonyl)-2-pyridylamine
1,1,1-trifluoro-N-pyridin-2-yl-N-(trifluoromethylsulfonyl)methanesulfonamide
2-Pyridyltriflimide
1,1,1-Trifluoro-N-(pyridin-2-yl)-N-((trifluoromethyl)sulfonyl)methanesulfonamide
 
Molecular Formula: C7H4F6N2O4S2
Molecular weight:358.23800
 
Appearance and properties: white to almost white crystal or powder
Density: 1.832 g/cm3
Boiling point: 80-90 °C 0.25 mm Hg(lit.)
Melting point: 40-42 °C(lit.)
Flash point: 230 °F
Refractive index: 1.485
Storage conditions: Refrigerator (+4ºC)

 
Our company is committed to establishing a complete fluorochemical products and technology platform to provide customers with convenient one-stop services. Our products are widely used in the manufacture of new materials, pharmaceutical research and development and the development of new pesticides. The fluorine product categories include fluorine-containing material raw materials, fluorinated reagents, fluorine-containing building blocks, fluorine-containing reagents and fluorine-containing gases for synthesis. Shanghai Fluorine Technology will strive to build a complete industrial chain from fluorine-containing raw material procurement, fluorination technology research and development, fluorine-containing product production, fluorine-containing product storage, fluorine-containing product quality control and fluorine-containing product application.
 



Market News: It comes as AZ’s flagship EGFR inhibitor Tagrisso has just been included for national reimbursement in China in the front-line setting.2-pyrrolidin-3-yl-1,3-thiazole manufacturer.McNamara joined GSK from Novartis in 2015 when the two companies combined their OTC portfolios into a joint venture managed by GSK. He became head of GSK consumer health in 2016, taking the baton from Walmsley as she moved up the command chain to CEO of the entire group. Novartis in 2018 backed out of the collab, and after taking full control of the venture, GSK formed a new JV with Pfizer in 2019. PLpro inhibitor supplier François-Henri Boissel, CEO of NOVA, commented: “Grégoire is an industry trail blazer with over two decades of experience in innovation, product strategy and digital entrepreneurship. Methyl 4-methoxy-1-methyl-1H-indole-2-carboxylate producer

Related Products
Product Name
2-Chloro-1,4-phenylene Bis[4-[6-(acryloyloxy)hexyloxy]benzoate] Cas:150809-90-8 View Details
5,7-Dihydro-2-methylthieno[3,4-d]pyrimidine View Details
4-methylsulfanyl-2-[[3-phenyl-2-(phenylmethoxycarbonylamino)propanoyl]amino]butanoic acid View Details
1-bromo-1,1,2,2,3,3,4,4,4-nonafluorobutane Cas:375-48-4 manufacturer N-Tallow-propane-1,3-diamine Cas:61791-55-7 manufacturer n-hexadecenylsuccinic anhydride Cas:32072-96-1 manufacturer 4-CYANO-4′-PENTYLBIPHENYL Cas:40817-08-1 manufacturer 4-[3-(Dibutylamino)propoxy]benzoic acid hydrochloride manufacturer